China's Nuclear Medicine Field Achieves Milestone: Domestically Produced Lutetium-177 Isotope Enters Market
1 day ago / Read about 0 minute
Author:小编   

On June 25, a significant advancement was announced by China's pioneering isotope production technology brand, the 'Hefu No.1' project. The Qinshan Nuclear Power Base, operated by the China National Nuclear Corporation, has successfully commenced large-scale production of lutetium-177 utilizing commercial heavy water reactors. With an annual irradiation capacity exceeding 10,000 curies, this milestone will adequately meet the demand of the national market, representing another crucial breakthrough in China's independent medical isotope production capabilities.